Views on growth hormone treatment in idiopathic shortness of stature
CGD Brook,
Corresponding Author
CGD Brook
London Centre for Paediatric Endocrinology at Great Ormond Street and The Middlesex Hospitals, London, UK
CGDBrook, London Centre for Paediatric Endocrinology, The Middlesex, Hospital, London W1N 8AA, UK
Search for more papers by this author
CGD Brook,
Corresponding Author
CGD Brook
London Centre for Paediatric Endocrinology at Great Ormond Street and The Middlesex Hospitals, London, UK
CGDBrook, London Centre for Paediatric Endocrinology, The Middlesex, Hospital, London W1N 8AA, UK
Search for more papers by this author
First published: 02 January 2007
No abstract is available for this article.
References
- 1
Phillip M,
Hershkovitz E,
Belotserkovsky O,
Leiberman E,
Limoni Y,
Zadik Z.
Once versus twice daily injections of growth hormone in children with idiopathic short stature.
Acta Paediatr
1998; 87: 518–20
- 2
Hindmarsh PC,
Fall CHD,
Pringle PJ,
Osmond C,
Brook CGD.
Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters.
J Clin Endocrinol Metabol
1997; 82: 2172–6
- 3
Brook CGD,
Hindmarsh, PC,
Stanhope R.
Growth and growth hormone secretion.
J Endocr
1988; 119: 179–84
- 4
Coste J,
Letrait M,
Carel J-C,
Tresca J-P,
Chatelain P,
Rochiccioli P, et al.
Long term results of growth hormone treatment in France in children of short stature.
Br Med J
1997; 315: 708–13
- 5
Downie AB,
Mulligan J,
Stratford RJ,
Betts PR,
Voss LD.
Are short children at a disadvantage
Br Med J
1997; 314: 97–100
- 6
de Herder WW,
van der Lely AJ,
Lamberts SWJ.
Colorectal cancer screening in acromegaly.
Clin Endocrinol
1997; 47: 644–6
- 7
Sonksen P,
Jacobs H,
Orme S,
Belchetz P.
Acromegaly and colon cancer.
Clin Endocrinol
1997; 47: 647–8
